News Focus
News Focus
icon url

Number sleven

11/18/24 5:57 AM

#430607 RE: Pharmacydude #430602

PDude, Good to hear from you. I can understand how an argument could be made that this class of drug might provide indirect competition. As investors I don't think we need to be overly concerned.
Sleven,